Recently, I, Xuewu Liu, had an insightful meeting with the Chlorine Dioxide Testimonies team from the U.S. (Telegram group: @ChlorineDioxideTestimonies). The discussion revolved around the latest advancements in intratumoral chlorine dioxide therapy, its application in cancer treatment, and our efforts to expand clinical adoption. Below is a detailed summary of the key topics covered.
Generated by AI. Please verify for accuracy.
Meeting Notes:
Meeting Setup:
Lili, Dave, and J discussed meeting setup issues, including camera and caption settings. Xuewu also participated in testing the functionality of translating from Chinese to English.
Camera Issue: Dave's camera could not turn on; he resolved it by closing some applications.
Caption Settings: J guided Dave on how to enable captioning in Teams for Chinese-to-English translation.
Translation Test: Xuewu spoke in Chinese to test the caption translation functionality, and J confirmed that the translation worked properly.
CDs Treatment Protocol:
Xuewu provided details about their CDs (chlorine dioxide solution) treatment protocol, highlighting how high-concentration chlorine dioxide is injected into tumors to kill cancer cells and disrupt tumor blood vessels.
Treatment Protocol: Xuewu explained the three key aspects of the CDs treatment protocol: regeneration, immune modulation, and cancer treatment.
Injection Method: Xuewu described in detail how high-concentration chlorine dioxide is directly injected into tumors to ensure drug efficacy and safety.
Clinical Cases: Xuewu mentioned two cases from a clinic in Germany where the tumor structure was disrupted after injection, and cancer pain was alleviated.
Safety: Xuewu emphasized the safety of high-concentration chlorine dioxide injections, explaining that they do not harm normal tissue.
Misconceptions About Aluminum:
Lili and J inquired about the use of aluminum. Xuewu clarified that their treatments do not involve aluminum.
Risks of Intravenous Injection:
Xuewu explained why injecting chlorine dioxide into the bloodstream is not recommended. High-concentration chlorine dioxide reacts quickly with blood cells and may damage blood vessels.
Intravenous Risks: Xuewu elaborated on the risks of injecting high-concentration chlorine dioxide into the blood, such as potential damage to vascular endothelial cells.
Experimental Results: Xuewu referred to mouse experiments where high-concentration chlorine dioxide injections led to tail detachment, demonstrating its vasculature-damaging effects.
Challenges in Treating Leukemia:
Xuewu detailed why CDs are currently unsuitable for treating leukemia, as it is difficult to ensure that chlorine dioxide targets only cancer cells without harming normal cells.
Leukemia Treatment: Xuewu explained the primary reason CDs cannot be used to treat leukemia—difficulty in ensuring selective targeting of cancer cells.
Other Cancers: Xuewu mentioned successful cases of CDs treating other types of cancers, such as pancreatic, liver, and brain cancers.
Collaboration in Germany and Mexico:
Xuewu shared their collaborations with clinics in Germany and Mexico, training doctors on preparing and using high-concentration chlorine dioxide injections for cancer treatment.
Training Collaboration: Xuewu discussed how they train doctors in Germany and Mexico to prepare and use high-concentration chlorine dioxide injections.
Clinical Data: Xuewu noted that in seven cases at a German clinic, tumors shrank by 70% to 90%, with remarkable results.
Challenges in Brain Tumor Treatment:
Xuewu discussed the challenges of treating brain tumors, including the need for specialized equipment and the risk of edema.
Brain Tumors: Xuewu explained the complexity and risks of treating brain tumors, such as the need for specialized equipment and the potential for edema.
Future Research: Xuewu expressed hopes to collaborate with well-equipped hospitals to conduct brain tumor treatment research.
Future Collaboration and Research:
Xuewu expressed a desire to collaborate with more international universities and top-tier hospitals to further study and promote their treatments and eventually file for new drug approvals.
International Collaboration: Xuewu hopes to collaborate with international universities and top-tier hospitals to further research and expand their treatment methods.
New Drug Applications: Xuewu expressed a goal of filing for new drug approvals in various countries so the treatment can be integrated into modern medical systems and covered by insurance.
Equipment and Preparation Methods:
Xuewu provided guidance on preparing chlorine dioxide solutions of various concentrations and offered to ship equipment from China to help team members prepare the required solutions.
Preparation Methods: Xuewu explained how to prepare chlorine dioxide solutions of varying concentrations using specialized equipment.
Equipment Shipping: Xuewu stated that they could ship equipment from China to help team members prepare 3000-7000 ppm chlorine dioxide solutions.
Follow-Up Tasks:
Doctor Training: Contact U.S. doctors to discuss the feasibility of treating cancer with chlorine dioxide injections and provide guidance. (Dave)
Visa Application: Prepare an invitation letter signed by doctors to assist Xuewu in applying for a U.S. visa. (J)
Equipment Shipping: Send the necessary equipment to team members requiring the preparation of 3000-7000 ppm chlorine dioxide solutions. (Xuewu)
Follow-Up Meeting: Arrange the next meeting with doctors who support chlorine dioxide treatments. (J, Dave)
Research Collaboration: Seek partnerships with international universities and top-tier hospitals for brain tumor research. (Xuewu)
WhatsApp Communication: Share contact information with team members via WhatsApp to address questions. (Xuewu)
Share this post